Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inspyr Therapeutics Inc (OTCQB:NSPX)

0.50
Delayed Data
As of Jun 23
 0.00 / 0.00%
Today’s Change
0.30
Today|||52-Week Range
5.01
-9.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization6.0K5.0K5.0K6.0K
 
 
 
 
 
 
Operating ExpensesGross Income-6.0K-5.0K-5.0K-6.0K
 
 
 
 
 
General Expenses701.0K883.0K560.0K919.0K
 
 
 
 
 
Research And Development323.0K379.0K76.0K465.0K
 
 
 
 
 
Total Operating Expenses707.0K888.0K565.0K925.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-707.0K-888.0K-565.0K-925.0K
 
 
 
 
 
Extraordinary Credit217.0K0.002.1M1.7M
 
 
 
 
Extraordinary Charge0.00-334.0K0.000.00
 
 
Interest Expense On Debt0.000.002.9M1.4M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-490.0K-1.2M-1.4M-659.0K
 
 
 
 
 
Net Income-490.0K-1.2M-1.4M-659.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.4M1.4M1.4M1.5M
 
 
 
 
 
Shares To Calculate EPS Diluted1.4M1.4M1.4M1.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$26.40-$0.97-$0.45
 
 
 
 
 
EPS Diluted-$0.30-$0.88-$0.97-$0.45